{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:28Z","timestamp":1788498988756,"version":"build-2803163510"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic peripheral neuropathy (DPN) is a prevalent and severe microvascular complication of type 2 diabetes mellitus (T2DM). Early risk screening and warning are critical for slowing disease progression. The triglyceride-glucose (TyG) index, a simple and efficient surrogate marker for assessing insulin resistance (IR), has been proven to be closely associated with various diabetic complications. However, existing studies on the association between the TyG index and the risk of DPN have yielded inconsistent findings, and relevant evidence still lacks systematic synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted. We systematically searched databases including PubMed, Embase, Web of Science, CNKI, Wanfang, and CQVIP to enroll observational studies exploring the association between the TyG index and the risk of DPN in patients with T2DM. Two investigators independently performed literature screening, data extraction, and quality assessment. The random-effects and fixed-effects models were applied to pool effect sizes, and subgroup analyses were carried out to explore potential sources of heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 14 studies involving 32,281 participants were included. The results showed that a higher TyG index was associated with an increased risk of DPN, with a pooled odds ratio (OR) of 2.614 (95% CI: 1.788-3.821,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.0001) and a pooled hazard ratio (HR) of 1.248 (95% CI: 1.003-1.553,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.0471). This positive correlation remained consistent across most subgroups stratified by age, sample size, BMI, and adjustment for confounding factors. However, the association did not reach statistical significance in the non-China subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated TyG levels are associated with an increased risk of DPN in patients with T2DM. However, the causal relationship requires further validation. These findings may serve as a reference for clinical screening of DPN risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero<\/jats:ext-link>\n                      , identifier CRD420261373476.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1901899","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:10Z","timestamp":1788496030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between the triglyceride-glucose index and diabetic peripheral neuropathy: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Xin","family":"Gu","sequence":"first","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoying","family":"Wei","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Wu","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijing","family":"Li","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Sun","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Guo","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoshuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Churan","family":"Wang","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yincheng","family":"Li","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Gong","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2026.113103","article-title":"Global prevalence of diabetes-related neuropathy and vascular complications: a systematic review and meta-analysis","volume":"232","author":"Burhan","year":"2026","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.671257","article-title":"Advances in screening, early diagnosis and accurate staging of diabetic neuropathy","volume":"12","author":"Carmichael","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7326\/m20-1340","article-title":"Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study","volume":"174","author":"Hicks","year":"2021","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03954-6","article-title":"Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy","volume":"86","author":"Bromberg","year":"2024","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1038\/s41598-021-94284-4","article-title":"Using corneal confocal microscopy to compare Mecobalamin intramuscular injections vs oral tablets in treating diabetic peripheral neuropathy: a RCT","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1380929","article-title":"Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach","volume":"15","author":"Atmaca","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.106429","article-title":"Effectiveness of current diagnostic methods in the early detection of diabetic peripheral neuropathy: are we missing the window","volume":"18","author":"Liaqat","year":"2026","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2018.01.003","article-title":"Better diagnostic accuracy of neuropathy in obesity: a new challenge for neurologists","volume":"129","author":"Callaghan","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/jcm8050598","article-title":"Feasibility and effectiveness of electrochemical dermal conductance measurement for the screening of diabetic neuropathy in primary care. Decoding study (Dermal Electrochemical Conductance in Diabetic Neuropathy)","volume":"8","author":"Cabre","year":"2019","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05846-8","article-title":"Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy","volume":"66","author":"Maalmi","year":"2023","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110988","article-title":"Serum neurofilament light chain - a potential biomarker for polyneuropathy in type 2 diabetes","volume":"205","author":"M\u00e4\u00e4tt\u00e4","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v13.i29.108380","article-title":"Mini-review on insulin resistance assessment: advances in surrogate indices and clinical applications","volume":"13","author":"Moriyama","year":"2025","journal-title":"World J Clin cases"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/jci77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/jdr\/9080699","article-title":"Diabetic peripheral neuropathy: current epidemiology, diagnostic advances, biomarkers, and management strategies","volume":"2026","author":"Kurz","year":"2026","journal-title":"J Diabetes Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/j.pain.0000000000001922","article-title":"Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms","volume":"161","author":"Calcutt","year":"2020","journal-title":"Pain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.2.178","article-title":"Triglyceride-glucose index is a useful marker for predicting future cardiovascular disease and mortality in young Korean adults: a nationwide population-based cohort study","volume":"11","author":"Cho","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"B22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/07435800.2023.2245909","article-title":"Assessment of triglyceride\u2013glucose index and ratio in patients with type 2 diabetes and their relation to microvascular complications","volume":"48","author":"Kassab","year":"2023","journal-title":"Endocr Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.12056\/j.issn.1006-2785.2024.46.23.2023-1297","article-title":"The clinical significance of PLR, NLR, SII, TyG, and TyG-BMI in peripheral neuropathy among patients with newly diagnosed T2DM","volume":"46","author":"Cai","year":"2024","journal-title":"Zhejiang Med J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mendia","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S012","article-title":"Retinopathy, neuropathy, and foot care: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1212\/01.Wnl.0000149522.32823.Ea","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15831","article-title":"Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment","volume":"30","author":"Truini","year":"2023","journal-title":"Eur J Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.19538\/j.nk2021090106","article-title":"Chinese guidelines for the prevention and treatment of type 2 diabetes (2020 edition) (part 2)","volume":"41","year":"2021","journal-title":"Chin J Pract Internal Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/s0140-6736(05)72963-9","article-title":"AHRQ's evidence-based practice centres prove viable. Agency for Healthcare Research and Quality","volume":"356","author":"Newman","year":"2000","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.22037\/aaemj.v13i1.2678","article-title":"Calculation of sensitivity and specificity from partial data for meta-analyses: introducing some practical methods","volume":"13","author":"Khatami","year":"2025","journal-title":"Arch Acad Emerg Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70263","article-title":"Prognostic value of triglyceride-derived metabolic parameters for micro- and macrovascular complications and mortality in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study","volume":"43","author":"Cardoso","year":"2026","journal-title":"Diabetic Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120407","article-title":"Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetes","volume":"407","author":"Cao","year":"2025","journal-title":"Atherosclerosis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8230","DOI":"10.1038\/s41598-026-39777-w","article-title":"Triglyceride-glucose index, genetic susceptibility, and trajectory of microvascular multimorbidity in type 2 diabetes","volume":"16","author":"Yuan","year":"2026","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12933-025-02671-2","article-title":"Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes","volume":"24","author":"Sbriscia","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90363","article-title":"Correlation of triglyceride-glucose index and the presence of microvascular complications of diabetes","volume":"17","author":"Miranda","year":"2025","journal-title":"Cureus"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01609-3","article-title":"Triglyceride glucose index for the detection of diabetic kidney disease and diabetic peripheral neuropathy in hospitalized patients with type 2 diabetes","volume":"15","author":"Tu","year":"2024","journal-title":"Diabetes Ther"},{"key":"B43","article-title":"The association of triglyceride-glucose index and neutrophil-to-lymphocyte ratio with type 2 diabetic peripheral neuropathy","volume":"32","author":"Yang","year":"2025","journal-title":"Labeled Immunoassays Clin Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2096-305X.2025.03.010","article-title":"The correlation between TyG index and diabetic peripheral neuropathy","volume":"46","author":"Zhang","year":"2025","journal-title":"J Jinzhou Med Univ"},{"key":"B45","article-title":"The predictive value of different insulin resistance indices and blood pressure variability for peripheral neuropathy in patients with hypertension and diabetes","volume":"36","author":"Mai","year":"2025","journal-title":"J Aerospace Med"},{"key":"B46","article-title":"The predictive value of the triglyceride-glucose index for type 2 diabetes with peripheral neuropathy","volume":"20","author":"Xu","year":"2022","journal-title":"J China Prescription Drug"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-6187.2023.02.005","article-title":"Correlation between triglyceride-glucose index and diabetic vascular complications","volume":"31","author":"Deng","year":"2023","journal-title":"Chin J Diabetes"},{"key":"B48","article-title":"Correlation of serum UA\/HDL-C ratio and TyG index with peripheral neuropathy in elderly patients with type 2 diabetes mellitus and their predictive value","volume":"46","author":"Yang","year":"2026","journal-title":"Chin J Gerontol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.3390\/molecules30224448","article-title":"Potential molecular biomarkers for predicting and monitoring complications in type 2 diabetes mellitus","volume":"30","author":"Shariat-Madar","year":"2025","journal-title":"Molecules"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00581","article-title":"A role for insulin in diabetic neuropathy","volume":"10","author":"Grote","year":"2016","journal-title":"Front Neurosci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1900\/rds.2022.18.157","article-title":"Sarcopenia and chronic complications of type 2 diabetes mellitus","volume":"18","author":"Purnamasari","year":"2022","journal-title":"Rev Diabetes Stud"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.11.003","article-title":"Adipose tissue content, muscle performance and physical function in obese adults with type 2 diabetes mellitus and peripheral neuropathy","volume":"29","author":"Bittel","year":"2015","journal-title":"J Diabetes Complications"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/nu16010172","article-title":"The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases","volume":"16","author":"Lopez-Pedrosa","year":"2024","journal-title":"Nutrients"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.3.700","article-title":"The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study","volume":"55","author":"Cho","year":"2014","journal-title":"Yonsei Med J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.12659\/msm.939157","article-title":"Analysis of factors related to type 2 diabetic peripheral neuropathy based on flash glucose monitoring system","volume":"29","author":"Ma","year":"2023","journal-title":"Med Sci Monit"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/bf00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.1852-20.2021","article-title":"High dietary fat consumption impairs axonal mitochondrial function in vivo","volume":"41","author":"Sajic","year":"2021","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1055\/a-2279-7112","article-title":"Association between triglyceride-glucose index and diabetic retinopathy: A meta-analysis","volume":"56","author":"Yu","year":"2024","journal-title":"Horm Metab Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1055\/a-2376-6044","article-title":"Triglyceride glucose index and the risk of diabetic nephropathy in patients with type 2 diabetes: A meta-analysis","volume":"57","author":"Deng","year":"2025","journal-title":"Horm Metab Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/met.2011.0108","article-title":"The triglyceride paradox in people of African descent","volume":"10","author":"Yu","year":"2012","journal-title":"Metab Syndr Relat Disord"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1701371","article-title":"Association between the triglyceride-glucose index and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations","volume":"17","author":"Chen","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e002261","DOI":"10.3390\/ijerph19020624","article-title":"Metabolic obesity in people with normal body weight (MONW)-Review of diagnostic criteria","volume":"19","author":"Pluta","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"S82\u20138","DOI":"10.1016\/j.dsx.2016.01.035","article-title":"The normal-weight type 2 diabetes phenotype revisited","volume":"10","author":"Hermans","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02201-5","article-title":"The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices","volume":"47","author":"Weyman-Vela","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112387","article-title":"Lean diabetes is one end of the spectrum of type 2 diabetes and not a separate entity","volume":"227","author":"Mohan","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/bmjdrc-2021-002261","article-title":"Insulin resistance versus insulin deficiency: evidence of racial differences in the pathogenesis of type 2 diabetes","volume":"9","author":"Garg","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/cm9.0000000000003034","article-title":"Pancreatic \u03b2-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes","volume":"137","author":"Cui","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3266","article-title":"Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)","volume":"36","author":"Schaper","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pcd.2019.05.008","article-title":"Variability in the clinical diagnosis of diabetic peripheral neuropathy","volume":"14","author":"Chicharro-Luna","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"B73","doi-asserted-by":"publisher","first-page":"I22-053","DOI":"10.7547\/l22-053","article-title":"Predictors of peripheral neuropathy among persons with diabetes mellitus: a multicenter cross-sectional study","volume":"115","author":"Lawal","year":"2025","journal-title":"J Am Podiatr Med Assoc"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-002333","article-title":"Prevalence and determinants of complications of type 2 diabetes in a community screening program in Kerala","volume":"3","author":"Sreedevi","year":"2025","journal-title":"BMJ Public Health"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030400","article-title":"Are inflammatory markers important for assessing the severity of diabetic polyneuropathy","volume":"61","author":"Uslu","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.6019","article-title":"Investigation of the relationship between the triglyceride-glucose index and metabolic and hematological parameters in obese individuals","volume":"55","author":"Bas Aksu","year":"2025","journal-title":"Turk J Med Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S65500","article-title":"Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study","volume":"7","author":"Hern\u00e1ndez-Ojeda","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jpp\/rgac104","article-title":"Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review","volume":"75","author":"Daliri","year":"2023","journal-title":"J Pharm Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11481-025-10200-x","article-title":"Dapagliflozin ameliorate type-2 diabetes associated neuropathy via regulation of IGF-1R signaling","volume":"20","author":"Kaur","year":"2025","journal-title":"J Neuroimmune Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1809007","article-title":"Association of the triglyceride glucose index and its related indices with coronary artery disease risk: mediation by glycated haemoglobin","volume":"17","author":"Sun","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12933-025-02620-z","article-title":"The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study","volume":"24","author":"Fang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:16Z","timestamp":1788496036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":82,"alternative-id":["10.3389\/fendo.2026.1901899"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1901899","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1901899"}}